See every side of every news story
Published loading...Updated

Lynch Regenerative Medicine acquires exclusive rights to REGRANEX® gel

Summary by Teknovation
Lynch Regenerative Medicine LLC (LRM) announced on Monday that it has acquired exclusive rights to REGRANEX® gel and recombinant purified platelet-derived growth factor (PDGF) from Smith & Nephew Inc. for use in skin rejuvenation and regeneration as well as other soft tissue wound healing and tissue regeneration applications. According to the announcement from the Franklin, TN-based company, PDGF is the first and only pure recombinant growth fac…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Teknovation broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.